Staurosporine stands as a prominent kinase inhibitor, exerting influence over a spectrum of protein kinases which could have downstream regulatory effects on C9orf43 activity. By inhibiting these kinases, staurosporine indirectly modulates various signaling cascades within cells, which, in turn, might affect the functionality or regulation of C9orf43. Similarly, LY294002 and Wortmannin, both phosphoinositide 3-kinases (PI3K) inhibitors, disrupt critical cellular signaling pathways by preventing the phosphorylation of PI3K substrates, thereby potentially altering the cellular context in which C9orf43 operates. In the realm of the mitogen-activated protein kinase (MAPK) pathway, U0126 and PD98059, both MEK inhibitors, intervene in the kinase cascade that is pivotal for cell division and differentiation, which could intersect with the biological pathways involving C9orf43. Rapamycin, an mTOR inhibitor, adds another layer of complexity by influencing cellular growth and metabolism, processes that are essential for the proper functioning of numerous proteins, possibly including C9orf43.
SB203580, a p38 MAP kinase inhibitor, specifically targets the inflammatory signaling pathways, which can have far-reaching implications on protein functions across the cell, including those associated with C9orf43. The c-Jun N-terminal kinase (JNK) pathway, implicated in the cellular stress response, is targeted by SP600125, a JNK inhibitor, providing a means to potentially alter the cellular environment of C9orf43. Beyond the signaling pathways, epigenetic modulators like Trichostatin A, a histone deacetylase inhibitor, and 5-Azacytidine, a DNA methyltransferase inhibitor, can broadly impact gene expression profiles, which could include the modulation of C9orf43 expression. Brefeldin A, by disrupting the Golgi apparatus, may indirectly influence proteins involved in trafficking and processing, including C9orf43. Thapsigargin, through its inhibition of the SERCA pump, perturbs calcium homeostasis, a fundamental aspect of cell biology with potential ramifications for a multitude of proteins and cellular processes wherein C9orf43 may be implicated.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
Inhibits protein kinases which may downstream regulate C9orf43 activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
PI3K inhibitor, alters signaling pathways that could intersect with C9orf43 functions. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
MEK inhibitor, affects MAPK pathway which might modulate proteins interacting with C9orf43. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
mTOR inhibitor, can influence cellular processes that C9orf43 could be implicated in. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
p38 MAP kinase inhibitor, alters inflammatory response pathways potentially linked to C9orf43. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
PI3K inhibitor, similar to LY294002 in affecting pathways that C9orf43 could partake in. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor, can modulate stress response pathways that might affect C9orf43's role in the cell. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
MEK inhibitor, similar to U0126, with possible effects on pathways involving C9orf43. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Histone deacetylase inhibitor, can alter gene expression profiles potentially including C9orf43. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
DNA methyltransferase inhibitor, can change DNA methylation status, possibly affecting C9orf43 expression. | ||||||